Skip to main content
Elsevier

Behavioral Pharmacology of Drug Abuse: Current Status

  • 1st Edition, Volume 93 - March 10, 2022
  • Latest edition
  • Editor: Jun-Xu Li
  • Language: English

Behavioral Pharmacology of Drug Abuse: Current Status, Volume 93 provides an update on our current understanding of animal and human behavioral pharmacology in major classes o… Read more

Description

Behavioral Pharmacology of Drug Abuse: Current Status, Volume 93 provides an update on our current understanding of animal and human behavioral pharmacology in major classes of drugs of abuse, including nicotine, alcohol, opioids, psychostimulants, and hallucinogens, drug-environment interactions, neurochemical mechanisms and medications developments. This volume updates the field of behavioral pharmacology based on new knowledge gained in the past decade.

Key features

  • Provides accurate and updated reviews from selected experts on covered topics
  • Presents useful graphic material for ease of reading
  • Covers a wide range of topics that are highly integral to offer a panoramic view of the field of behavioral pharmacology

Readership

Pharmacologists, medicinal chemists and graduate students who are interested in behavioral neuropharmacology of drug abuse

Table of contents

Preface
Jun-Xu Li

1. Interactions between opioids and stimulants: Behavioral pharmacology of abuse-related effects
David R. Maguire and Vanessa Minervini

2. In vitro and in vivo pharmacology of kratom
Takato Hiranita, Samuel Obeng, Abhisheak Sharma, Jenny L. Wilkerson, Christopher R. McCurdy and Lance R. McMahon

3. Human behavioral pharmacology of stimulant drugs: An update and narrative review
Ashley Strzelecki, Jessica Weafer and William W. Stoops

4. Human behavioral pharmacology of psychedelics
Justin C. Strickland and Matthew W. Johnson

5. Stimulus functions of nicotine
Mark G. LeSage

6. The incentive amplifying effects of nicotine: Roles in alcohol seeking and consumption
Christopher P. King and Paul J. Meyer

7. Environmental influence on the preclinical evaluation of substance use disorder therapeutics
Matthew L. Banks

8. Examining the effects of psychoactive drugs on complex behavioral processes in laboratory animals
Brian D. Kangas

9. Receptor mechanisms underlying the CNS effects of cannabinoids: Beyond the CB1 receptor
Briana Hempel and Zheng-Xiong Xi

10. Potential therapeutic targets for the treatment of opioid abuse and pain
Norikazu Kiguchi and Mei-Chuan Ko

11. Trace amine-associated receptor 1 and drug abuse
Ruyan Wu, Jianfeng Liu and Jun-Xu Li

12. Substance abuse and neurotransmission
Sarah Davis and Jun Zhu

Product details

  • Edition: 1
  • Latest edition
  • Volume: 93
  • Published: March 25, 2022
  • Language: English

About the editor

JL

Jun-Xu Li

Jun-Xu Li received his MD degree at Binzhou Medical University in 2o0o; In 2005 he received his Ph.D in pharmacology at Peking University. He received his postdoctoral training between 2005-2010 at the University of Texas Health Science Center at San Antonio. In 2010 he joined the faculty of Department of Pharmacology and Toxicology at the State University of New York at Buffalo and is currently a professor in the same department. He has authored more than 120 papers and is currently an associate editor of Pharmacology & Therapeutics. He serves as an reviewer for numerous scientific journals and several grant agencies. He is the past chair of Behavioral Pharmacology Division of American Society of Pharmacology and Experimental Therapeutics (ASPET) and Upstate New York Pharmacology Society. He received several awards including the Joseph Cochin Young Investigator Award from the College on Problems of Drug Dependence and the JH Woods Early Career Award in Behavioral Pharmacology from ASPET.
Affiliations and expertise
University at Buffalo, Buffalo, New York, USA

View book on ScienceDirect

Read Behavioral Pharmacology of Drug Abuse: Current Status on ScienceDirect